| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 128,966 | 89,701 | 67,575 | 93,969 | | Cost of Revenue | 70,955 | 37,037 | 30,552 | 41,462 | | | Gross Profit | 58,011 | 52,664 | 37,023 | 52,507 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 57,409 | 49,547 | 48,142 | 76,490 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 602 | 3,117 | (11,119) | (23,983) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (113) | 149 | 51 | 920 | | Earnings Before Interest And Taxes | 489 | 3,266 | (11,068) | (23,063) | | Interest Expense | 951 | 2,301 | 545 | 724 | | Income Before Tax | (462) | 965 | (11,613) | (23,787) | | Income Tax Expense | 21,947 | 481 | (2,703) | (1,066) | | Minority Interest | (232) |
-
|
-
| (78) | | | | Net Income From Continuing Ops | (22,641) | 484 | (8,910) | (22,799) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (22,641) | 484 | (8,910) | (22,799) | | Preferred Stock And Other Adjustments | 6 | 44 | (50) |
-
| | | Net Income Applicable To Common Shares | ($22,635) | $528 | ($8,960) | ($22,799) |
|
0.23% Nasdaq 
Income Statement
